General Manager Cheng Zhenghui of APT Medical Inc. (688617.SH) plans to reduce his shareholding by no more than 1.5%.
APT Medical Inc. (688617.SH) announced that today the company received a "Notification Letter Regarding the Share Reduction Plan" from Mr. Cheng Zhenghui, a shareholder holding more than 5% of the company's shares, Vice Chairman, and General Manager. The reducing shareholder intends to reduce its holdings of the company's shares through block trades, totaling no more than 2,122,900 shares, i.e., no more than 1.5% of the company's total share capital.
APT Medical Inc. (688617.SH) announced that today the company received a "Notification Letter Regarding the Share Reduction Plan" issued by Mr. Cheng Zhenghui, a shareholder holding more than 5% of the company's shares, Vice Chairman, and General Manager. The reducing shareholder intends to reduce its holdings of the company's shares through block trades, totaling no more than 2,122,900 shares, i.e., no more than 1.5% of the company's total share capital.
Related Articles
Shandong Xinhua Pharmaceutical (000756.SZ) obtained the drug registration certificate for Magnesium Sulfate, Sodium Sulfate, and Potassium Sulfate Oral Concentrated Solution.
Shandong Xinhua Pharmaceutical (000756.SZ) subsidiary obtains drug registration certificate for Donepezil Hydrochloride Orally Disintegrating Tablets.
Shandong Xinhua Pharmaceutical (000756.SZ) obtained the drug registration certificate for Levocarnitine Oral Solution.
Shandong Xinhua Pharmaceutical (000756.SZ) obtained the drug registration certificate for Magnesium Sulfate, Sodium Sulfate, and Potassium Sulfate Oral Concentrated Solution.
Shandong Xinhua Pharmaceutical (000756.SZ) subsidiary obtains drug registration certificate for Donepezil Hydrochloride Orally Disintegrating Tablets.
Shandong Xinhua Pharmaceutical (000756.SZ) obtained the drug registration certificate for Levocarnitine Oral Solution.
RECOMMEND
